The DOI matches its Crossref record; 157 of the 157 references it cites were found in a registry or an index.
Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
Abstract
Nonalcoholic steatohepatitis (NASH), the lynchpin between steatosis and cirrhosis in the spectrum of nonalcoholic fatty liver disorders (NAFLD), was barely recognized in 1981. NAFLD is now present in 17% to 33% of Americans, has a worldwide distribution, and parallels the frequency of central adiposity, obesity, insulin resistance, metabolic syndrome and type 2 diabetes. NASH could be present in one third of NAFLD cases. Age, activity of steatohepatitis, and established fibrosis predispose to cirrhosis, which has a 7- to 10-year liver-related mortality of 12% to 25%. Many cases of cryptogenic cirrhosis are likely endstage NASH. While endstage NAFLD currently accounts for 4% to 10% of liver transplants, this may soon rise. Pathogenic concepts for NAFLD/NASH must account for the strong links with overnutrition and underactivity, insulin resistance, and genetic factors. Lipotoxicity, oxidative stress, cytokines, and other proinflammatory mediators may each play a role in transition of steatosis to NASH. The present “gold standard” management of NASH is modest weight reduction, particularly correction of central obesity achieved by combining dietary measures with increased physical activity. Whether achieved by “lifestyle adjustment” or anti-obesity surgery, this improves insulin resistance and reverses steatosis, hepatocellular injury, inflammation, and fibrosis. The same potential for “unwinding” fibrotic NASH is indicated by studies of the peroxisome proliferation activator receptor (PPAR)- γ agonist “glitazones,” but these agents may improve liver disease at the expense of worsening obesity. Future challenges are to approach NAFLD as a preventive public health initiative and to motivate affected persons to adopt a healthier lifestyle. (Hepatology 2006;43:S99-S112.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions
Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A., & Bacon, B. R. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01377.x · Cited by 3,907
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345
Ludwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R., Natale, S., Vanni, E., Villanova, N., Melchionda, N., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50161 · Cited by 2,679
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245
Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
Neuschwander-Tetri, B. A., & Caldwell, S. H. (2003) · Hepatology · doi:10.1053/jhep.2003.50193 · Cited by 2,154
The utility of radiological imaging in nonalcoholic fatty liver disease
Saadeh, S., Younossi, Z. M., Remer, E. M., Gramlich, T., Ong, J. P., Hurley, M., Mullen, K. D., Cooper, J. N., & Sheridan, M. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.35354 · Cited by 2,110
Mitochondrial dysfunction in the elderly: possible role in insulin resistance
Petersen, K. F., Befroy, D., Dufour, S., Dziura, J., Ariyan, C., Rothman, D. L., DiPietro, L., Cline, G. W., & Shulman, G. I. (2003) · Science · doi:10.1126/science.1082889 · Cited by 2,107
Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease
Ratziu, V., Charlotte, F., Heurtier, A., Gombert, S., Giral, P., Bruckert, E., Grimaldi, A., Capron, F., & Poynard, T. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.084 · Cited by 2,106
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078
Mitochondrial dysfunction and type 2 diabetes
Lowell, B. B., & Shulman, G. I. (2005) · Science · doi:10.1126/science.1104343 · Cited by 2,070
Molecular mediators of hepatic steatosis and liver injury
Browning, J. D., & Horton, J. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422422 · Cited by 1,772
Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
Angulo, P., Keach, J. C., Batts, K. P., & Lindor, K. D. (1999) · Hepatology · doi:10.1002/hep.510300604 · Cited by 1,610
Szczepaniak, L. S., Nurenberg, P., Leonard, D., Browning, J. D., Reingold, J. S., Grundy, S., Hobbs, H. H., & Dobbins, R. L. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00064.2004 · Cited by 1,562
Powell, E. E., Cooksley, G. W. E., Hanson, R., Searle, J., Halliday, J. W., & Powell, L. W. (1990) · Hepatology · doi:10.1002/hep.1840110114 · Cited by 1,473
Bugianesi, E., Leone, N., Vanni, E., Marchesini, G., Brunello, F., Carucci, P., Musso, A., De Paolis, P., Capussotti, L., Salizzoni, M., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.34168 · Cited by 1,439
Dixon, J. B., Bhathal, P. S., & O'Brien, P. E. (2001) · Gastroenterology · doi:10.1053/gast.2001.25540 · Cited by 1,360
Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
Samuel, V. T., Liu, Z.-X., Qu, X., Elder, B. D., Bilz, S., Befroy, D., Romanelli, A. J., & Shulman, G. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313478200 · Cited by 1,322
Xu, A., Wang, Y., Keshaw, H., Xu, L. Y., Lam, K. S. L., & Cooper, G. J. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317797 · Cited by 1,298
Xu, A., Wang, Y., Keshaw, H., Xu, L. Y., Lam, K. S. L., & Cooper, G. J. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17797 · Cited by 1,296
Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study
Foucher, J. (2006) · Gut · doi:10.1136/gut.2005.069153 · Cited by 1,284
Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy
Bellentani, S., Saccoccio, G., Masutti, F., Crocè, L. S., Brandi, G., Sasso, F., Cristanini, G., & Tiribelli, C. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-2-200001180-00004 · Cited by 1,265
Mofrad, P., Contos, M. J., Haque, M., Sargeant, C., Fisher, R. A., Luketic, V. A., Sterling, R. K., Shiffman, M. L., Stravitz, R. T., & Sanyal, A. J. (2003) · Hepatology · doi:10.1053/jhep.2003.50229 · Cited by 1,201
Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors.
Wanless, I. R., & Lentz, J. S. (1990) · Hepatology · doi:10.1002/hep.1840120505 · Cited by 1,191
Nonalcoholic steatohepatitis: An expanded clinical entity
Bacon, B. R., Farahvash, M. J., Janney, C. G., & Neuschwander-Tetri, B. A. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90235-6 · Cited by 1,144
Chitturi, S., Abeygunasekera, S., Farrell, G. C., Holmes-Walker, J., Hui, J. M., Fung, C., Karim, R., Lin, R., Samarasinghe, D., Liddle, C., et al. (2002) · Hepatology · doi:10.1053/jhep.2002.30692 · Cited by 1,122
Self-citationSerum markers detect the presence of liver fibrosis: A cohort study
Rosenberg, W. M. C., Voelker, M., Thiel, R., Becka, M., Burt, A., Schuppan, D., Hubscher, S., Roskams, T., Pinzani, M., & Arthur, M. J. P. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.08.052 · Cited by 1,102
Beyond insulin resistance in NASH: TNF-α or adiponectin?
Hui, J. M., Hodge, A., Farrell, G. C., Kench, J. G., Kriketos, A., & George, J. (2004) · Hepatology · doi:10.1002/hep.20280 · Cited by 942
Self-citationAdams, L. A., Sanderson, S., Lindor, K. D., & Angulo, P. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2004.09.012 · Cited by 911
Nonalcoholic fatty liver disease
Clark, J. M., Brancati, F. L., & Diehl, A. M. (2002) · Gastroenterology · doi:10.1053/gast.2002.33573 · Cited by 901
CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis
Leclercq, I. A., Farrell, G. C., Field, J., Bell, D. R., Gonzalez, F. J., & Robertson, G. R. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8814 · Cited by 764
Self-citationMusso, G., Gambino, R., De Michieli, F., Cassader, M., Rizzetto, M., Durazzo, M., Fagà, E., Silli, B., & Pagano, G. (2003) · Hepatology · doi:10.1053/jhep.2003.50132 · Cited by 759
Pagano, G., Pacini, G., Musso, G., Gambino, R., Mecca, F., Depetris, N., Cassader, M., David, E., Cavallo-Perin, P., & Rizzetto, M. (2002) · Hepatology · doi:10.1053/jhep.2002.30690 · Cited by 753
Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance
Kim, J. K., Fillmore, J. J., Chen, Y., Yu, C., Moore, I. K., Pypaert, M., Lutz, E. P., Kako, Y., Velez-Carrasco, W., Goldberg, I. J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121164498 · Cited by 753
Neuschwander-Tetri, B. A., Brunt, E. M., Wehmeier, K. R., Oliver, D., & Bacon, B. R. (2003) · Hepatology · doi:10.1002/hep.1840380427 · Cited by 751
Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis
Harrison, S. A., Torgerson, S., Hayashi, P. H., Ward, J. A., & Schenker, S. (2003) · The American Journal of Gastroenterology · doi:10.1016/j.amjgastroenterol.2003.08.005 · Cited by 731
Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial
Lindor, K. D., Kowdley, K. V., Heathcote, J. E., Harrison, E. M., Jorgensen, R., Angulo, P., Lymp, J. F., Burgart, L., & Colin, P. (2004) · Hepatology · doi:10.1002/hep.20092 · Cited by 727
Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss
Dixon, J. B., Bhathal, P. S., Hughes, N. R., & O'Brien, P. E. (2004) · Hepatology · doi:10.1002/hep.20251 · Cited by 727
A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis
Promrat, K., Lutchman, G., Uwaifo, G. I., Freedman, R. J., Soza, A., Heller, T., Doo, E., Ghany, M., Premkumar, A., Park, Y., et al. (2004) · Hepatology · doi:10.1002/hep.20012 · Cited by 726
Davila, J. A., Morgan, R. O., Shaib, Y., McGlynn, K. A., & El-Serag, H. B. (2005) · Gut · doi:10.1136/gut.2004.052167 · Cited by 704
Bugianesi, E., Gentilcore, E., Manini, R., Natale, S., Vanni, E., Villanova, N., David, E., Rizzetto, M., & Marchesini, G. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41583.x · Cited by 691
Etiopathogenesis of Nonalcoholic Steatohepatitis
Chitturi, S., & Farrell, G. C. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-12927 · Cited by 661
Self-citationMarrero, J. A., Fontana, R. J., Su, G. L., Conjeevaram, H. S., Emick, D. M., & Lok, A. S. (2002) · Hepatology · doi:10.1002/hep.1840360609 · Cited by 660
George, D. K., Goldwurm, S., Macdonald, G. A., Cowley, L. L., Walker, N. I., Ward, P. J., Jazwinska, E. C., & Powell, L. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70482-2 · Cited by 659
Liver Pathology and the Metabolic Syndrome X in Severe Obesity
Marceau, P. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.5.1513 · Cited by 635
Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis
Weltman, M. D., Farrell, G. C., Hall, P., Ingelman-Sundberg, M., & Liddle, C. (1998) · Hepatology · doi:10.1002/hep.510270121 · Cited by 614
Self-citationTherapeutic effects of restricted diet and exercise in obese patients with fatty liver
Ueno, T., Sugawara, H., Sujaku, K., Hashimoto, O., Tsuji, R., Tamaki, S., Torimura, T., Inuzuka, S., Sata, M., & Tanikawa, K. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80287-5 · Cited by 609
Development of Muscle Insulin Resistance After Liver Insulin Resistance in High-Fat–Fed Rats
Kraegen, E. W., Clark, P. W., Jenkins, A. B., Daley, E. A., Chisholm, D. J., & Storlien, L. H. (1991) · Diabetes · doi:10.2337/diab.40.11.1397 · Cited by 601
Laurin, J., Lindor, K. D., Crippin, J. S., Gossard, A., Gores, G. J., Ludwig, J., Rakela, J., & McGill, D. B. (1996) · Hepatology · doi:10.1002/hep.510230624 · Cited by 566
Paradis, V., Perlemuter, G., Bonvoust, F., Dargere, D., Parfait, B., Vidaud, M., Conti, M., Huet, S., Ba, N., Buffet, C., et al. (2001) · Hepatology · doi:10.1053/jhep.2001.28055 · Cited by 542
Vitamin E treatment of nonalcoholic steatohepatitis in children: A pilot study
Lavine, J. E. (2000) · The Journal of Pediatrics · doi:10.1016/s0022-3476(00)05040-x · Cited by 531
Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease
Joseph, A. E. A., Saverymuttu, S. H., Al-Sam, S., Cook, M. G., & Maxwell, J. D. (1991) · Clinical Radiology · doi:10.1016/s0009-9260(05)80350-2 · Cited by 515
Mitochondrial abnormalities in non-alcoholic steatohepatitis
Caldwell, S. H., Swerdlow, R. H., Khan, E. M., Iezzoni, J. C., Hespenheide, E. E., Parks, J. K., & Parker, W. D. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80033-6 · Cited by 498
Liver abnormalities in severely obese subjects: Effect of drastic weight loss after gastroplasty
Luyckx, F., Desaive, C., Thiry, A., Dewé, W., Scheen, A., Gielen, J., & Lefèbvre, P. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800571 · Cited by 489
The natural history of nonalcoholic fatty liver disease: a clinical histopathological study
Harrison, S. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(03)00622-1 · Cited by 482
Natural history of nonalcoholic steatohepatitis: A longitudinal study of repeat liver biopsies
Fassio, E., �lvarez, E., Dom�nguez, N., Landeira, G., & Longo, C. (2004) · Hepatology · doi:10.1002/hep.20410 · Cited by 469
Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis
Ratziu, V., Bonyhay, L., Di Martino, V., Charlotte, F., Cavallaro, L., Sayegh-Tainturier, M.-H., Giral, P., Grimaldi, A., Opolon, P., & Poynard, T. (2002) · Hepatology · doi:10.1053/jhep.2002.33324 · Cited by 464
Jimba, S., Nakagami, T., Takahashi, M., Wakamatsu, T., Hirota, Y., Iwamoto, Y., & Wasada, T. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01582.x · Cited by 455
Huang, M. A., Greenson, J. K., Chao, C., Anderson, L., Peterman, D., Jacobson, J., Emick, D., Lok, A. S., & Conjeevaram, H. S. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41334.x · Cited by 444
Bugianesi, E., Manzini, P., D'Antico, S., Vanni, E., Longo, F., Leone, N., Massarenti, P., Piga, A., Marchesini, G., & Rizzetto, M. (2004) · Hepatology · doi:10.1002/hep.20023 · Cited by 440
Abdelmalek, M. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)02691-0 · Cited by 439
Sanyal, A. J., Mofrad, P. S., Contos, M. J., Sargeant, C., Luketic, V. A., Sterling, R. K., Stravitz, R. T., Shiffman, M. L., Clore, J., & Mills, A. S. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00457-4 · Cited by 437
Long–Term Outcomes of Cirrhosis in Nonalcoholic Steatohepatitis Compared With Hepatitis C
Hui, J. M., Kench, J. G., Chitturi, S., Sud, A., Farrell, G. C., Byth, K., Hall, P., Khan, M., & George, J. (2003) · Hepatology · doi:10.1053/jhep.2003.50320 · Cited by 437
Self-citationHickman, I. J., Jonsson, J. R., Prins, J. B., Ash, S., Purdie, D. M., Clouston, A. D., & Powell, E. E. (2004) · Gut · doi:10.1136/gut.2003.027581 · Cited by 435
Adiponectin and its receptors in non-alcoholic steatohepatitis
Kaser, S., Moschen, A., Cayon, A., Kaser, A., Crespo, J., Pons-Romero, F., Ebenbichler, C. F., Patsch, J. R., & Tilg, H. (2005) · Gut · doi:10.1136/gut.2003.037010 · Cited by 412
Hasegawa, T., Yoneda, M., Nakamura, K., Makino, I., & Terano, A. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.01083.x · Cited by 408
Bugianesi, E., Pagotto, U., Manini, R., Vanni, E., Gastaldelli, A., de Iasio, R., Gentilcore, E., Natale, S., Cassader, M., Rizzetto, M., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2240 · Cited by 408
Adiponectin protects LPS-induced liver injury through modulation of TNF-α in KK-Ay obese mice
Masaki, T., Chiba, S., Tatsukawa, H., Yasuda, T., Noguchi, H., Seike, M., & Yoshimatsu, H. (2004) · Hepatology · doi:10.1002/hep.20282 · Cited by 402
Fatty liver hepatitis and cirrhosis in obese patients
Adler, M., & Schaffner, F. (1979) · The American Journal of Medicine · doi:10.1016/0002-9343(79)90740-x · Cited by 399
Obesity and hepatocellular carcinoma
Caldwell, S. H., Crespo, D. M., Kang, H. S., & Al-Osaimi, A. M. S. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.021 · Cited by 396
Ip, E., Farrell, G., Hall, P., Robertson, G., & Leclercq, I. (2004) · Hepatology · doi:10.1002/hep.20170 · Cited by 383
Self-citationEffect of weight reduction on hepatic abnormalities in overweight patients
Palmer, M., & Schaffner, F. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)91169-7 · Cited by 374
Steatosis: Co-factor in Other Liver Diseases *
Powell, E. E., Jonsson, J. R., & Clouston, A. D. (2005) · Hepatology · doi:10.1002/hep.20750 · Cited by 374
Bonkovsky, H. L., Jawaid, Q., Tortorelli, K., LeClair, P., Cobb, J., Lambrecht, R. W., & Banner, B. F. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80032-4 · Cited by 360
II. Cytochrome P-450 enzymes and oxidative stress
Robertson, G., Leclercq, I., & Farrell, G. C. (2001) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2001.281.5.g1135 · Cited by 358
Self-citationHepatocellular carcinoma in patients with non-alcoholic steatohepatitis
Shimada, M., Hashimoto, E., Taniai, M., Hasegawa, K., Okuda, H., Hayashi, N., Takasaki, K., & Ludwig, J. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00099-5 · Cited by 356
Prevalence of fatty liver in a general population of Okinawa, Japan.
NOMURA, H., KASHIWAGI, S., HAYASHI, J., KAJIYAMA, W., TANI, S., & GOTO, M. (1988) · Japanese Journal of Medicine · doi:10.2169/internalmedicine1962.27.142 · Cited by 355
Hepatic Cytochrome P450 2E1 Activity in Nondiabetic Patients With Nonalcoholic Steatohepatitis
Chalasani, N., Gorski, C. J., Asghar, M. S., Asghar, A., Foresman, B., Hall, S. D., & Crabb, D. W. (2003) · Hepatology · doi:10.1053/jhep.2003.50095 · Cited by 348
Diagnosis of fatty liver disease: is biopsy necessary?
Joy, D., Thava, V. R., & Scott, B. B. (2003) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200305000-00014 · Cited by 341
Apolipoprotein synthesis in nonalcoholic steatohepatitis
Charlton, M., Sreekumar, R., Rasmussen, D., Lindor, K., & Nair, S. K. (2002) · Hepatology · doi:10.1053/jhep.2002.32527 · Cited by 333
Recent concepts in non‐alcoholic fatty liver disease
Adams, L. A., & Angulo, P. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01748.x · Cited by 324
Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis
Kral, J. G., Thung, S. N., Biron, S., Hould, F.-S., Lebel, S., Marceau, S., Simard, S., & Marceau, P. (2004) · Surgery · doi:10.1016/j.surg.2003.10.003 · Cited by 322
A high‐fat diet leads to the progression of non‐alcoholic fatty liver disease in obese rats
Carmiel-Haggai, M., Cederbaum, A. I., & Nieto, N. (2005) · The FASEB Journal · doi:10.1096/fj.04-2291fje · Cited by 318
Thomas, E. L., Hamilton, G., Patel, N., O’Dwyer, R., Doré, C. J., Goldin, R. D., Bell, J. D., & Taylor-Robinson, S. D. (2005) · Gut · doi:10.1136/gut.2003.036566 · Cited by 317
The Role of Ultrasound in the Diagnosis of Hepatic Steatosis in Morbidly Obese Patients
Mottin, C. C., Moretto, M., Padoin, A. V., Swarowsky, A. M., Toneto, M. G., Glock, L., & Repetto, G. (2004) · Obesity Surgery · doi:10.1381/096089204323093408 · Cited by 301
Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds
Struben, V. M. D., Hespenheide, E. E., & Caldwell, S. H. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00315-0 · Cited by 296
dela Peña, A., Leclercq, I., Field, J., George, J., Jones, B., & Farrell, G. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.09.004 · Cited by 287
Self-citationHepatic MRI for Fat Quantitation: Its Relationship to Fat Morphology, Diagnosis, and Ultrasound
Fishbein, M., Castro, F., Cheruku, S., Jain, S., Webb, B., Gleason, T., & Stevens, W. R. (2005) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200508000-00012 · Cited by 277
Fatty liver in non‐alcoholic non‐overweight Japanese adults: Incidence and clinical characteristics
Omagari, K., Kadokawa, Y., Masuda, J., Egawa, I., Sawa, T., Hazama, H., Ohba, K., Isomoto, H., Mizuta, Y., Hayashida, K., et al. (2002) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2002.02846.x · Cited by 275
Selection and Outcome of Living Donors for Adult to Adult Right Lobe Transplantation
Marcos, A., Fisher, R. A., Ham, J. M., Olzinski, A. T., Shiffman, M. L., Sanyal, A. J., Luketic, V. A. C., Sterling, R. K., Olbrisch, M. E., & Posner, M. P. (2000) · Transplantation · doi:10.1097/00007890-200006150-00034 · Cited by 272
Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease
Charlton, M., Kasparova, P., Weston, S., Lindor, K., Maor-Kendler, Y., Wiesner, R. H., Rosen, C. B., & Batts, K. P. (2001) · Liver Transplantation · doi:10.1053/jlts.2001.25453 · Cited by 261
Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction
Adams, L. A., Feldstein, A., Lindor, K. D., & Angulo, P. (2004) · Hepatology · doi:10.1002/hep.20140 · Cited by 252
Chitturi, S., Weltman, M., Farrell, G. C., McDonald, D., Liddle, C., Samarasinghe, D., Lin, R., Abeygunasekera, S., & George, J. (2002) · Hepatology · doi:10.1053/jhep.2002.33892 · Cited by 247
Self-citationGeorge, J., Pera, N., Phung, N., Leclercq, I., Yun Hou, J., & Farrell, G. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00376-3 · Cited by 247
Self-citationLiver Histology in a ‘Normal’ Population—Examinations of 503 Consecutive Fatal Traffic Casualties
Hilden, M., Christoffersen, P., Juhl, E., & Dalgaard, J. B. (1977) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365527709181339 · Cited by 243
Hepatic iron and nonalcoholic fatty liver disease
Younossi, Z. M., Gramlich, T., Bacon, B. R., Matteoni, C. A., Boparai, N., O'Neill, R., & McCullough, A. J. (1999) · Hepatology · doi:10.1002/hep.510300407 · Cited by 238
Non‐alcoholic steatohepatitis: What is it, and why is it important in the Asia–Pacific region?
FARRELL, G. C. (2003) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2003.02989.x · Cited by 235
Self-citationA Pilot Trial of Pentoxifylline in Nonalcoholic Steatohepatitis
Adams, L. A., Zein, C. O., Angulo, P., & Lindor, K. D. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.40064.x · Cited by 234
Cytokines and the pathogenesis of non-alcoholic steatohepatitis
Diehl, A. M., Li, Z. P., Lin, H. Z., & Yang, S. Q. (2005) · Gut · doi:10.1136/gut.2003.024935 · Cited by 216
Steatohepatitis Induced by Intragastric Overfeeding in Mice *
Deng, Q.-G., She, H., Cheng, J. H., French, S. W., Koop, D. R., Xiong, S., & Tsukamoto, H. (2005) · Hepatology · doi:10.1002/hep.20877 · Cited by 215
Suzuki, A., Angulo, P., Lymp, J., Li, D., Satomura, S., & Lindor, K. (2005) · Liver International · doi:10.1111/j.1478-3231.2005.01064.x · Cited by 214
Dietary Composition and Nonalcoholic Fatty Liver Disease
Solga, S., Alkhuraishe, A. R., Clark, J. M., Torbenson, M., Greenwald, A., Diehl, A. M., & Magnuson, T. (2004) · Digestive Diseases and Sciences · doi:10.1023/b:ddas.0000043367.69470.b7 · Cited by 213
Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice
McCuskey, R. S., Ito, Y., Robertson, G. R., McCuskey, M. K., Perry, M., & Farrell, G. C. (2004) · Hepatology · doi:10.1002/hep.20302 · Cited by 210
Self-citationPARK, S. H., KIM, B. I., YUN, J. W., KIM, J. W., PARK, D. I., CHO, Y. K., SUNG, I. K., PARK, C. Y., SOHN, C. I., JEON, W. K., et al. (2004) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2004.03362.x · Cited by 198
Hepatocyte CYP2E1 overexpression and steatohepatitis lead to impaired hepatic insulin signaling
Schattenberg, J. M., Wang, Y., Singh, R., Rigoli, R. M., & Czaja, M. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410310200 · Cited by 194
Non‐alcoholic fatty liver syndrome: A hepatic consequence of common metabolic diseases
ANGELICO, F., DEL BEN, M., CONTI, R., FRANCIOSO, S., FEOLE, K., MACCIONI, D., ANTONINI, T. M., & ALESSANDRI, C. (2003) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2003.02958.x · Cited by 191
Body fat topography as an independent predictor of fatty liver
Kral, J. G., Schaffner, F., Pierson, R. N., & Wang, J. (1993) · Metabolism · doi:10.1016/0026-0495(93)90210-f · Cited by 176
Cryptogenic cirrhosis: Clinicopathologic findings at and after liver transplantation
Ayata, G., Gordon, F. D., Lewis, W. D., Pomfret, E., Pomposelli, J. J., Jenkins, R. L., & Khettry, U. (2002) · Human Pathology · doi:10.1053/hupa.2002.129419 · Cited by 173
Fibrosis in Patients with Chronic Hepatitis C: Detection and Significance
Poynard, T., Ratziu, V., Benmanov, Y., Di Martino, V., Bedossa, P., & Opolon, P. (2000) · Seminars in Liver Disease · doi:10.1055/s-2000-9258 · Cited by 172
Regression of Hepatic Steatosis in Morbidly Obese Persons After Gastric Bypass
Silverman, E. M., Sapala, J. A., & Appelman, H. D. (1995) · American Journal of Clinical Pathology · doi:10.1093/ajcp/104.1.23 · Cited by 164
(2004) · Wiley eBooks · doi:10.1002/9780470987438 · Cited by 156
Insulin resistance, adiponectin, cytokines in NASH: Which is the best target to treat?
Larter, C. Z., & Farrell, G. C. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.11.030 · Cited by 155
Self-citationSakugawa, H. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i2.255 · Cited by 155
Alcohol consumption and the risk of alcohol related cirrhosis in women.
Norton, R., Batey, R., Dwyer, T., & MacMahon, S. W. (1987) · BMJ · doi:10.1136/bmj.295.6590.80 · Cited by 154
Pathologic features associated with fibrosis in nonalcoholic fatty liver disease
Gramlich, T. L., Kleiner, D. E., McCullough, A. J., Matteoni, C. A., Boparai, N., & Younossi, Z. M. (2004) · Human Pathology · doi:10.1016/j.humpath.2003.09.018 · Cited by 145
Non‐alcoholic steatohepatitis in children and adolescents
Manton, N. D., Lipsett, J., Moore, D., Davidson, G. P., Bourne, A. J., & Couper, R. T. L. (2000) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2000.tb139299.x · Cited by 139
Diabetes duration and cause-specific mortality in the Verona Diabetes Study.
Brun, E., Nelson, R. G., Bennett, P. H., Imperatore, G., Zoppini, G., Verlato, G., Muggeo, M., & Study, V. D. (2000) · Diabetes Care · doi:10.2337/diacare.23.8.1119 · Cited by 135
Friedman, J. M. (2002) · Nature · doi:10.1038/415268a · Cited by 127
Focal manifestations of diffuse liver disease at MR imaging.
Mitchell, D. G. (1992) · Radiology · doi:10.1148/radiology.185.1.1523289 · Cited by 119
The Epidemiology and Risk Factors of NASH
McCullough, A. J. (2004) · Wiley eBooks · doi:10.1002/9780470987438.ch3 · Cited by 110
Efficacy and Safety of Oral Betaine Glucuronate in Non-alcoholic Steatohepatitis
Miglio, F., Rovati, L. C., Santoro, A., & Setnikar, I. (2011) · Arzneimittelforschung · doi:10.1055/s-0031-1300279 · Cited by 106
Controversies in liver biopsy: Who, where, when, how, why?
Friedman, L. S. (2004) · Current Gastroenterology Reports · doi:10.1007/s11894-004-0023-4 · Cited by 106
Subacute liver failure in obese women
Caldwell, S. H., & Hespenheide, E. E. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)04279-x · Cited by 93
The effect of donor weight reduction on hepatic steatosis for living donor liver transplantation
Hwang, S., Lee, S., Jang, S.-J., Cho, S.-H., Kim, K., Ahn, C., Moon, D., & Ha, T. (2004) · Liver Transplantation · doi:10.1002/lt.20172 · Cited by 93
Crespo, J., Fernández-Gil, P. L., Hernández‐Guerra, M., Cayón, A., Mayorga, M. M., Domínguez‐Díez, A., Fernández-Escalante, J. C., & Pons‐Romero, F. (2001) · Obesity Surgery · doi:10.1381/096089201321336548 · Cited by 84
Capron, J., Delamarre, J., Dupas, J., Braillon, A., Degott, C., & Quenum, C. (1982) · Digestive Diseases and Sciences · doi:10.1007/bf01296926 · Cited by 79
Ioannou, G. N., Weiss, N. S., Boyko, E. J., Kahn, S. E., & Lee, S. P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.12.004 · Cited by 77
Liver injury in the setting of steatosis: Crosstalk between adipokine and cytokine†
Czaja, M. J. (2004) · Hepatology · doi:10.1002/hep.20328 · Cited by 70
Bezafibrate for tamoxifeninduced non-alcoholic steatohepatitis
Saibara, T., Onishi, S., Ogawa, Y., Yoshida, S., & Enzan, H. (1999) · The Lancet · doi:10.1016/s0140-6736(05)75907-9 · Cited by 70
Ground, K. E. (1982) · PubMed · Cited by 70
Proposal for a histological scoring and grading system for non‐alcoholic fatty liver disease
Mendler, M. H., Kanel, G. C., & Govindarajan, S. (2005) · Liver International · doi:10.1111/j.1478-3231.2005.01052.x · Cited by 67
Hui, J. M., Farrell, G. C., Kench, J. G., & George, J. (2004) · Hepatology · doi:10.1002/hep.20223 · Cited by 61
Self-citationHepatic stellate cells and fibrosis progression in patients with nonalcoholic fatty liver disease
Feldstein, A. E., Papouchado, B. G., Angulo, P., Sanderson, S., Adams, L. A., & Gores, G. J. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00616-0 · Cited by 60
Hayashi, P. H., Harrison, S. A., Torgerson, S., Perez, T. A., Nochajski, T. H., & Russell, M. (2004) · The American Journal of Gastroenterology · doi:10.1046/j.1572-0241.2003.04013.x · Cited by 60
Elkeles, R. S., Feher, M. D., Flather, M. D., Godsland, I. F., Nugara, F., Richmond, W., Rubens, M., & Wang, D. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01409.x · Cited by 58
Roberts, E. A. (2002) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2002.0331 · Cited by 56
Signalling links in the liver: Knitting SOCS with fat and inflammation
Farrell, G. C. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.04.004 · Cited by 51
Self-citationPatt, C. H., Yoo, H. Y., Dibadj, K., Flynn, J. A., & Thuluvath, P. J. (2003) · Digestive Diseases and Sciences · doi:10.1023/a:1022809430756 · Cited by 50
TNF-α is not the cause of fatty liver disease in obese diabetic mice
Memon, R. A., Grünfeld, C., & Feingold, K. R. (2001) · Nature Medicine · doi:10.1038/83316 · Cited by 44
Hashimoto, E., Taniai, M., Kaneda, H., Tokushige, K., Hasegawa, K., Okuda, H., Shiratori, K., & Takasaki, K. (2004) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2004.tb03237.x · Cited by 39
Hashimoto, E., Taniai, M., Kaneda, H., Tokushige, K., Hasegawa, K., Okuda, H., Shiratori, K., & Takasaki, K. (2004) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000133547.70803.83 · Cited by 35
Hui, J. M., & Farrell, G. C. (2003) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2003.03170.x · Cited by 30
Self-citationAtaseven, H., Yildirim, M. H., Yalnız, M., Bahçecioğlu, İ. H., Çelebı, S., & Özercan, İ. H. (2005) · PubMed · Cited by 25
Management of NASH: Current and Future Perspectives on Treatment
Angulo, P., & Lindor, K. D. (2004) · Wiley eBooks · doi:10.1002/9780470987438.ch16 · Cited by 4
Nash is A Genetically Determined Disease
Day, C. P., & Daly, A. K. (2004) · Wiley eBooks · doi:10.1002/9780470987438.ch6 · Cited by 3
Cited by
Schuppan, D., & Afdhal, N. H. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60383-9 · Cited by 2,089
Hepatocellular carcinoma pathogenesis: from genes to environment
Farazi, P. A., & DePinho, R. A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1934 · Cited by 1,979
A lipidomic analysis of nonalcoholic fatty liver disease
Puri, P., Baillie, R. A., Wiest, M. M., Mirshahi, F., Choudhury, J., Cheung, O., Sargeant, C., Contos, M. J., & Sanyal, A. J. (2007) · Hepatology · doi:10.1002/hep.21763 · Cited by 1,338
Taylor, R. S., Taylor, R. J., Bayliss, S., Hagström, H., Nasr, P., Schattenberg, J. M., Ishigami, M., Toyoda, H., Wai-Sun Wong, V., Peleg, N., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.01.043 · Cited by 1,069
Hagström, H., Nasr, P., Ekstedt, M., Hammar, U., Stål, P., Hultcrantz, R., & Kechagias, S. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.07.027 · Cited by 1,067
Metadata
- Authors
- Farrell, G. C., & Larter, C. Z.
- Venue
- Hepatology
- Published
- 2006-02
- Volume
- 43
- Issue
- Supplement 1
- Pages
- S99-S112
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2047257800
- Cited by
- 2,414
- References
- 157
- FWCI
- 86.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.